Related Experiment Video
Updated: Sep 19, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
New treatments for treatment-resistant depression: esketamine controversies - a narrative review
Maj Vinberg1,2
1The Early Multimodular Prevention and Intervention Research Institution (EMPIRI), Psychiatric Centre North Zealand, Copenhagen University Hospital - Mental Health Services CPH.
Abstract:
This narrative review examines barriers to Danish patients' timely access to new treatments for treatment-resistant depression, focusing on controversies around esketamine. Delays arise from regulatory complexity, economic constraints and scientific debate over novel psychotropics. The review advocates evidence-based, faster implementation pathways for new treatments to alleviate the overall individual and societal burden from severe depression in Denmark.
Related Concept Videos
Electroconvulsive Therapy
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Overview